A detailed history of Ossiam transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Ossiam holds 30,969 shares of GILD stock, worth $2.91 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
30,969
Previous 33,576 7.76%
Holding current value
$2.91 Million
Previous $2.3 Million 12.68%
% of portfolio
0.05%
Previous 0.04%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$66.59 - $83.99 $173,600 - $218,961
-2,607 Reduced 7.76%
30,969 $2.6 Million
Q2 2024

Aug 13, 2024

BUY
$63.15 - $72.88 $330,211 - $381,089
5,229 Added 18.45%
33,576 $2.3 Million
Q1 2024

May 13, 2024

SELL
$71.58 - $87.29 $765,906 - $934,003
-10,700 Reduced 27.4%
28,347 $2.08 Million
Q4 2023

Feb 13, 2024

BUY
$73.27 - $83.09 $399,761 - $453,339
5,456 Added 16.24%
39,047 $3.16 Million
Q3 2023

Nov 14, 2023

SELL
$73.94 - $80.67 $5.04 Million - $5.5 Million
-68,222 Reduced 67.01%
33,591 $2.52 Million
Q2 2023

Aug 11, 2023

BUY
$76.01 - $86.7 $6.24 Million - $7.12 Million
82,142 Added 417.58%
101,813 $7.85 Million
Q1 2023

May 12, 2023

BUY
$77.31 - $88.08 $122,459 - $139,518
1,584 Added 8.76%
19,671 $1.63 Million
Q4 2022

Feb 13, 2023

SELL
$62.32 - $89.47 $1.48 Million - $2.13 Million
-23,814 Reduced 56.83%
18,087 $1.55 Million
Q3 2022

Nov 14, 2022

SELL
$59.54 - $68.01 $3.8 Million - $4.34 Million
-63,807 Reduced 60.36%
41,901 $2.59 Million
Q2 2022

Aug 12, 2022

SELL
$57.72 - $65.01 $9.88 Million - $11.1 Million
-171,170 Reduced 61.82%
105,708 $6.53 Million
Q1 2022

May 13, 2022

BUY
$57.92 - $72.58 $5.89 Million - $7.38 Million
101,716 Added 58.07%
276,878 $16.5 Million
Q4 2021

Feb 14, 2022

SELL
$64.88 - $73.64 $1.15 Million - $1.3 Million
-17,652 Reduced 9.15%
175,162 $12.7 Million
Q3 2021

Nov 12, 2021

SELL
$67.69 - $73.03 $4.45 Million - $4.8 Million
-65,728 Reduced 25.42%
192,814 $13.5 Million
Q2 2021

Aug 13, 2021

BUY
$63.47 - $69.35 $1.68 Million - $1.84 Million
26,504 Added 11.42%
258,542 $17.7 Million
Q1 2021

May 17, 2021

BUY
$60.0 - $68.46 $5.42 Million - $6.18 Million
90,343 Added 63.76%
232,038 $15 Million
Q4 2020

Feb 12, 2021

BUY
$56.65 - $64.55 $4.05 Million - $4.61 Million
71,444 Added 101.7%
141,695 $8.26 Million
Q3 2020

Nov 12, 2020

BUY
$62.1 - $78.08 $60,671 - $76,284
977 Added 1.41%
70,251 $4.44 Million
Q2 2020

Aug 13, 2020

BUY
$72.34 - $84.0 $1.7 Million - $1.97 Million
23,456 Added 51.19%
69,274 $5.33 Million
Q1 2020

May 14, 2020

BUY
$62.63 - $80.22 $2.76 Million - $3.54 Million
44,127 Added 2609.52%
45,818 $3.43 Million
Q4 2019

Feb 14, 2020

BUY
$61.62 - $67.78 $85,405 - $93,943
1,386 Added 454.43%
1,691 $110,000
Q3 2019

Nov 13, 2019

SELL
$62.51 - $69.0 $2.55 Million - $2.82 Million
-40,835 Reduced 99.26%
305 $19,000
Q2 2019

Aug 13, 2019

BUY
$61.87 - $69.38 $2.55 Million - $2.85 Million
41,140 New
41,140 $2.78 Million
Q1 2019

May 15, 2019

SELL
$62.53 - $70.05 $13.8 Million - $15.4 Million
-219,960 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$60.54 - $79.0 $13.3 Million - $17.4 Million
219,960 New
219,960 $13.8 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Ossiam Portfolio

Follow Ossiam and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ossiam, based on Form 13F filings with the SEC.

News

Stay updated on Ossiam with notifications on news.